Exact Mass: 349.044247
Exact Mass Matches: 349.044247
Found 122 metabolites which its exact mass value is equals to given mass value 349.044247
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate
m-Cppamp
C16H16NO6P (349.07152060000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors D004791 - Enzyme Inhibitors
Ulifloxacin
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
1-(2-carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate
A deoxyribulose phosphate that is D-ribulose 5-phosphate in which the hydroxy group at position 1 is replaced by a 2-carboxyphenylamino group.
Loracarbef
Loracarbef is only found in individuals that have used or taken this drug. It is a carbacephem antibiotic sometimes grouped together with the second-generation cephalosporin antibiotics. It is marketed under the trade name Lorabid.Loracarbef is an oral, synthetic beta-lactam antibiotic of the carbacephem class. Chemically, carbacephems differ from cephalosporin-class antibiotics in the dihydrothiazine ring where a methylene group has been substituted for a sulfur atom. Loracarbef has a spectrum of activity similar to that of the second generation cephalosporins. It is structurally identical to cefaclor except for a sulfur atom that has been replaced by a methylene group. This change gives greater chemical stability in solution and allows storage at room temperature. Loracarbef, like all b-lactams and cephalosporins, inhibits penicillin binding proteins, enzymes that create the cross-linkage of the peptidoglycan polymer. This binding leads to interference with the formation and remodeling of the cell wall structure. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Silmitasertib
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-(4-((5-Chloro-3-fluoro-2-pyridinyl)oxy)phenoxy)propanoic acid 2-propyn-1-yl ester
C17H13ClFNO4 (349.05171000000007)
3-Dibenzofuran-3-yl-2-(phosphonomethylamino)propanoic acid
C16H16NO6P (349.07152060000004)
Hydroxytriamterene sulfate
C12H11N7O4S (349.05932060000004)
Clodinafop-propargyl
C17H13ClFNO4 (349.05171000000007)
CONFIDENCE standard compound; INTERNAL_ID 1315; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9499; ORIGINAL_PRECURSOR_SCAN_NO 9497 CONFIDENCE standard compound; INTERNAL_ID 1315; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9496; ORIGINAL_PRECURSOR_SCAN_NO 9491 CONFIDENCE standard compound; INTERNAL_ID 1315; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9519; ORIGINAL_PRECURSOR_SCAN_NO 9517 CONFIDENCE standard compound; INTERNAL_ID 1315; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9530; ORIGINAL_PRECURSOR_SCAN_NO 9528 CONFIDENCE standard compound; INTERNAL_ID 1315; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9535; ORIGINAL_PRECURSOR_SCAN_NO 9533 CONFIDENCE standard compound; INTERNAL_ID 1315; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9546; ORIGINAL_PRECURSOR_SCAN_NO 9545
1-(4-chlorophenyl)-3-[4-methyl-2-(thiophen-2-yl)-1,3-thiazol-5-yl]urea
O1-(4-sulfamoyl-phenyl)-beta-D-glucopyranuronic acid|O1-(4-Sulfamoyl-phenyl)-beta-D-glucopyranuronsaeure
C12H15NO9S (349.04675000000003)
3,6-bismethylthio-cyclo(alanyltryptophyl)
C16H19N3O2S2 (349.09186339999997)
(+)-7-bromotrypargine|7-bromotrypargine
C15H20BrN5 (349.09019800000004)
loracarbef
A synthetic "carba" analogue of cefaclor, with carbon replacing sulfur at position 1. Used to treat a wide range of infections caused by both gram-positive and gram-negative bacteria. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
2-amino-6-(3-chlorophenyl)-3-nitro-4-phenylbenzonitrile
ETHYL 2-(BENZOYL-3-CHLORO-4-FLUOROANILINO)PROPANOATE
C18H17ClFNO3 (349.08809340000005)
Thiazolidine, 3-[(4-methoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
C17H19NO3S2 (349.08063039999996)
2-([(4-BROMOPHENYL)SULFONYL]AMINO)-4-METHYLPENTANOIC ACID
acetaminophen glucuronide sodium salt
C14H16NNaO8 (349.07735759999997)
2-amino-6-(4-chlorophenyl)-3-nitro-4-phenylbenzonitrile
2-HYDROXY-3-(4-METHOXY-PHENYL)-3-(2-NITRO-PHENYLSULFANYL)-PROPIONIC ACID
4,6-Diamidino-2-phenylindole dihydrochloride
C16H17Cl2N5 (349.08609420000005)
2-[(6-chloro-4h-1,3-benzodioxin-8-yl)methoxy]-5-nitrobenzaldehyde
4-Piperidinol, 1-[(3-bromo-4-methoxyphenyl)sulfonyl]
METHYL 1-(4-CYANO-PHENYL)-5-(4-METHYLSULFANYL-PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
(R)-N-(2-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)phenyl)formamide
METHYL 2-BROMO-3-CYCLOHEXYL-1-METHYL-1H-INDOLE-6-CARBOXYLATE
C17H20BrNO2 (349.06773200000003)
7-chloro-1-(p-tolylsulfonyl)-3,4-dihydro-2H-1-benzazepin-5-one
C17H16ClNO3S (349.05393760000004)
2-CHLORO-N-(4-(1,1,1,3,3,3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL)PHENYL)-N-METHYLACETAMIDE
C12H10ClF6NO2 (349.03042220000003)
2-BENZYLOXY-1-METHYLPYRIDINIUM TRIFLUOROMETHANESULFONATE
C14H14F3NO4S (349.05956000000003)
3-[4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1,3-oxazol-2-yl]benzonitrile
N-[2-amino-3-nitro-5-(trifluoromethyl)phenyl]-2,2,3,3-tetrafluoro-prop anamide
C10H6F7N3O3 (349.02973700000007)
1-(4-fluoro-benzyl)-1h-indazol-5-ylamine trihydrochloride
naftalofos
C16H16NO6P (349.07152060000004)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
3-ethyl-2-methylbenzothiazolium p-toluenesulfonate
C17H19NO3S2 (349.08063039999996)
1-[3,5-bis(trifluoromethyl)phenyl]biguanide hydrochloride
C10H10ClF6N5 (349.05288820000004)
2-(4-isothiocyanatophenoxy)ethyl 4-methylbenzenesulfonate
6-(1,3-Dioxolo[4,5-g]isoquinolin-5-yl)furo[3,4-e]-1,3-benzodioxol-8(6H)-one
2-Amino-4-fluoro-5-[(1-methyl-1H-imidazol-2-yl)thio]-N-thiazol-2-ylbenzamide
4-[4-(BENZYLOXY)PHENYL]-5-(2-FURYL)-4H-1,2,4-TRIAZOLE-3-THIOL
BIS(CYCLOPENTADIENYL)TUNGSTEN CHLORIDE HYDRIDE
C10H10ClW (348.99805200000003)
Arsonic acid,As-[4-[2-[4-(dimethylamino)phenyl]diazenyl]phenyl]-
Sulopenem
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
8-Chloro-1,2,3,4-tetrahydro-1-[(4-methylphenyl)sulfonyl]-5H-1-benzazepin-5-one
C17H16ClNO3S (349.05393760000004)
2-(4-((5-Chloro-3-fluoro-2-pyridinyl)oxy)phenoxy)propanoic acid 2-propyn-1-yl ester
C17H13ClFNO4 (349.05171000000007)
(Z)-3-(5-(4-(allyloxy)benzylidene)-4-oxo-2-thioxothiazolidin-3-yl)propanoic acid
2-(4-benzofuro[3,2-d]pyrimidinylthio)-N-(3-methylphenyl)acetamide
2-[2-[[Benzamido(sulfanylidene)methyl]amino]-4-thiazolyl]acetic acid ethyl ester
(Z)-butyl 3-(5-benzylidene-4-oxo-2-thioxothiazolidin-3-yl)propanoate
C17H19NO3S2 (349.08063039999996)
4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]furan-2-Yl}benzenesulfonamide
7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(2E,4E)-4-[2-(5-carboxylato-2-hydroxy-3-methoxyphenyl)-2-oxoethylidene]-2-hydroxypent-2-enedioate
6,8-Dihydroxy-3-methyl-1,2,7,12-tetraoxobenzo[a]anthracen-4-olate
(6R,7S)-7-{[(2R)-2-ammonio-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
N-[[[2-(2-methoxyphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-furancarboxamide
N-(5-acetyl-2-phenyl-4-sulfanylidene-1H-pyrimidin-6-yl)benzamide
1-[[(2-Chlorophenyl)-oxomethyl]amino]-3-(2-methoxy-5-methylphenyl)thiourea
Propan-2-yl 2-(thiophene-2-carbonylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
C17H19NO3S2 (349.08063039999996)
4-(4-chloro-2-methylphenoxy)-N-[3-(methylthio)phenyl]butanamide
C18H20ClNO2S (349.0903210000001)
6-[(2-chloro-4-fluorophenyl)methyl]-5-methyl-7-oxo-1H-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid methyl ester
3-(1,3-benzodioxol-5-yl)-4-(3-chloro-4-fluorophenyl)-1H-1,2,4-triazole-5-thione
4-(4-Chlorophenyl)-4-oxobutanoic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester
(5E)-1-(2-fluorophenyl)-5-(1H-indol-3-ylmethylidene)-1,3-diazinane-2,4,6-trione
N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-7-nitro-1H-benzimidazole-4-carboxamide
3-(4-Chlorophenyl)-2-(2,3-dimethoxyphenyl)-1,3-thiazolidin-4-one
C17H16ClNO3S (349.05393760000004)
N-(2-furylmethylene)-2-(10H-phenothiazin-10-yl)acetohydrazide
N,N-bis(2-methoxyethyl)-2-thieno[3,2-b][1]benzothiolecarboxamide
C17H19NO3S2 (349.08063039999996)
N-(1,3-dimethyl-2-oxo-5-benzimidazolyl)-4-fluoro-3-methylbenzenesulfonamide
6-Amino-1-(4-fluorophenyl)-3-methyl-4-thiophen-2-yl-5-pyrazolo[3,4-b]pyridinecarbonitrile
C18H12FN5S (349.07974040000005)
N-(benzenesulfonamidocarbamothioyl)-4-methylbenzamide
2-[[4-(2-furanylmethyl)-5-methyl-1,2,4-triazol-3-yl]thio]-N-(4-methyl-2-thiazolyl)acetamide
4-[(E)-(5-bromo-1H-indol-3-yl)methylideneamino]-3-ethyl-1H-1,2,4-triazole-5-thione
2-(4-(Tert-butyl)benzamido)-4-chloro-5-fluorobenzoic acid
C18H17ClFNO3 (349.08809340000005)
2-[4-[(3-Chloro-4-methoxyanilino)-oxomethyl]phenoxy]propanoic acid
N-[2-[2-(2-bromo-4-chlorophenoxy)ethoxy]ethyl]-2-butanamine
C14H21BrClNO2 (349.04440960000005)
7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(E)-1-N-methyl-1-N-[2-[[2-(methylaminomethyl)-1,3-thiazol-4-yl]methylsulfonyl]ethyl]-2-nitroethene-1,1-diamine
3-Carboxyphenyl phenylacetamidomethylphosphonate
C16H16NO6P (349.07152060000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors D004791 - Enzyme Inhibitors
Ulifloxacin
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
Sirtuin modulator 2
Sirtuin modulator 2 (Compound 132) is a sirtuin modulator with an ED50 equal or less than 50 μM[1].